Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting ß2-agonists
Clinical trial NCT07546981 · RECRUITING
Trial details
- NCT number
- NCT07546981
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-26
- Primary completion
- 2028-10-17
- Enrollment
- 554
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.